OHE / News & Insights / Insights

Insights

Abstract white sculpture with intertwined curves against a black background, emphasizing form over detail.

Five unanswered questions from the UK’s Renewed Women’s Health Strategy

16 September 2026

The UK’s Renewed Women’s Health Strategy sets out an ambitious plan. But can the NHS deliver it?

Health Care SystemsPrevention
Low-angle view of tall glass skyscrapers reaching up into a clear blue sky with a bit of greenery at the bottom edge.

Compared to what? How the choice of comparator affects new medicines

14 September 2026

Comparator choice shapes health technology assessment: it sets the benchmark a new medicine is assessed against, driving both patient access and where firms invest in R&D. We consider five theoretical comparator examples and, for each, assess the implications of comparator selection on access, launch decisions and innovation incentives for new medicines.

Health Technology Assessment (HTA)
Front facade of the New York Stock Exchange building with classical columns and sculpted pediment, flanked by tall office towers and waving American flags, viewed from street level.

Why President Trump’s generic drug tariffs are unlikely to fix America’s supply problem

13 August 2026

America’s dependence on foreign generic manufacturing is a real national security and supply concern. The vast majority of drug shortages in the U.S. are generics and shortages have increasingly burdened pharmacies across the country and disrupted care for the patients who rely on them, particularly those with chronic pain and cancer.

But President Trump’s most recent policy is unlikely to fix that problem. It’s far more likely to make American medicine cabinets less reliable, not more.

Health Care Systems
Abstract outdoor sculpture of overlapping transparent umbrella frames attached to metal poles against a pink and blue sunset sky.

What the first EU JCA reveals about assessing precision oncology 

28 July 2026

We explore how the first JCA provides insights into the longstanding methodological challenge of evidence generation and comparative assessment for precision medicine.

Health Care Systems
Botanical Garden Fuveszkert in Budapest

What is a life worth in climate policy? It depends on who you ask 

22 July 2026

The ECOnomic Evaluation for Climate Action (ECO-CHICA) consensus guidance is now on SSRN, with the scoping review and methodological deep dives available alongside it. Here is what they say, and why the question in the title is harder than it looks.

Colorful red and yellow steps descending a narrow street with bunting, murals on the wall, and potted evergreens along the sides.

Around the World in HTAs: Spain – Closer than ever, but not quite yet

8 July 2026

Spain has introduced its first national legal framework for health technology assessment (HTA) through Royal Decree 415/2026. It is a significant step forward, but the system is still being built.

Health Technology Assessment (HTA)
Flock of swallows perched on power lines against blue sky background

How long are patients WAITing for new treatments?

2 July 2026

The latest EFPIA Patients W.A.I.T. Indicator 2025 Survey shows that patients across Europe are waiting longer for access to new medicines, with major differences between countries.  Here we explain how to interpret the W.A.I.T indicators. 

Limestone and glass museum by a reflective turquoise pool at sunset with a latticed dome roof (Louvre Abu Dhabi).

Around the world in HTAs: Abu Dhabi – Advancing HTA and value-based healthcare in the UAE

1 July 2026

Abu Dhabi is taking important steps to strengthen the use of HTA in healthcare decision-making, with the publication of its HTA guidelines in 2025 marking an important milestone.

Health Care SystemsHealth Technology Assessment (HTA)

Germany’s drug-pricing dilemma: Why Europe’s pivotal market holds the key to the MFN debate

25 June 2026

Much of the Most-Favoured-Nation debate asks whether the United States can persuade other countries to pay more for medicines. Germany is the market where that question is hardest to answer and where it matters most.